FibroGen Announces Sale of China Subsidiary to AstraZeneca for Approximately $160 Million
Source: NASDAQ Stocks / 20 Feb 2025 06:51:49 America/Chicago
FibroGen sells its China subsidiary to AstraZeneca for $160 million, extending cash runway and advancing oncology pipeline.
https://www.nasdaq.com/articles/fibrogen-announces-sale-china-subsidiary-astrazeneca-approximately-160-million